Illumina (ILMN):股价近期反弹后的估值探讨 - 雅虎财经
Illumina (ILMN): Exploring Valuation Following Recent Share Price Rebound - Yahoo Finance
生物技术与制药领域的最新动态
Illumina (ILMN): Exploring Valuation Following Recent Share Price Rebound - Yahoo Finance
Waters Corporation: Balancing Growth Opportunities and Challenges with a Hold Rating - TipRanks
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement - simplywall.st
Illumina, Inc. (NASDAQ:ILMN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected - simplywall.st
Agilent Technologies (NYSE:A) Could Easily Take On More Debt - Yahoo Finance
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey
Does 10x Genomics' (TXG) Q4 Outlook Signal Shifting Demand or Product Innovation Taking Hold? - Yahoo Finance
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
Regulatory, cGMP, and CDMO Challenges: A CPHI Conversation with Lonza Capsugel, Part Two - PharmTech.com
Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value - Seeking Alpha
Thermo Fisher Scientific Debuts Orbitrap Exploris EFOX Mass Detector - Food Engineering Mag
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact - Yahoo Finance
10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Markets Financial Content
10x Genomics Reports Third Quarter 2025 Financial Results - Barchart.com
10x Genomics Reports Third Quarter 2025 Financial Results - Eastern Progress
Targeted Protein Degradation: How Chemoproteomics and Induced Proximity Are Shaping Drug Discovery
Why Thermo Fisher Scientific Stock Jumped 40%? - Trefis